Allianz Asset Management
IDXX icon

Allianz Asset Management’s Idexx Laboratories IDXX Stock Holding History

Allianz Asset Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.9M Buy
3,600
+1,100
+44% +$617K ﹤0.01% 1747
2026
Q1 		$1.4M Sell
2,500
-1,300
-34% -$834K ﹤0.01% 1653
2025
Q4 		$2.57M Buy
3,800
+1,000
+36% +$681K ﹤0.01% 1453
2025
Q3 		$1.79M Buy
2,800
+1,100
+65% +$668K ﹤0.01% 1540
2025
Q2 		$912K Sell
1,700
-1,800
-51% -$861K ﹤0.01% 1690
2025
Q1 		$1.47M Buy
3,500
+2,600
+289% +$1.13M ﹤0.01% 1582
2024
Q4 		$372K Buy
+900
New +$395K ﹤0.01% 1950
2024
Q3 		– Sell
-800
Closed -$390K – 2228
2024
Q2 		$390K Buy
+800
New +$402K ﹤0.01% 1909
2024
Q1 		– Sell
-1,200
Closed -$666K – 2151
2023
Q4 		$666K Sell
1,200
-3,300
-73% -$1.55M ﹤0.01% 1755
2023
Q3 		$1.97M Buy
4,500
+3,900
+650% +$1.94M ﹤0.01% 1446
2023
Q2 		$301K Sell
600
-2,600
-81% -$1.25M ﹤0.01% 1836
2023
Q1 		$1.6M Buy
+3,200
New +$1.53M ﹤0.01% 1474
2022
Q2 		– Sell
-500
Closed -$274K – 2321
2022
Q1 		$274K Sell
500
-2,400
-83% -$1.26M ﹤0.01% 2238
2021
Q4 		$1.91M Sell
2,900
-1,100
-28% -$691K ﹤0.01% 1632
2021
Q3 		$2.49M Buy
4,000
+2,000
+100% +$1.34M ﹤0.01% 1576
2021
Q2 		$1.26M Buy
+2,000
New +$1.1M ﹤0.01% 1645
2020
Q3 		– Sell
-15,900
Closed -$5.25M – 2107
2020
Q2 		$5.25M Buy
15,900
+14,300
+894% +$4.14M 0.01% 1189
2020
Q1 		$388K Sell
1,600
-1,300
-45% -$339K ﹤0.01% 2145
2019
Q4 		$757K Sell
2,900
-400
-12% -$105K ﹤0.01% 2294
2019
Q3 		$897K Buy
3,300
+800
+32% +$223K ﹤0.01% 2167
2019
Q2 		$688K Buy
+2,500
New +$616K ﹤0.01% 2257

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Allianz Asset Management's IDXX Position: Q2 2026 in Review

Allianz Asset Management reduced its Idexx Laboratories (IDXX) stake by 30% in Q2 2026, selling an estimated $34.9M and leaving 145,168 shares worth $76.4M. The position accounts for 0.06% of the portfolio, ranked #290.

Allianz Asset Management first reported a position in IDXX in Q4 2013 and has held it in 43 quarters since. The position peaked at $199M in Q2 2021. 1,305 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Allianz Asset Management held 145,168 shares of Idexx Laboratories worth $76.4M as of Q2 2026.
  • Allianz Asset Management sold 62,235 Idexx Laboratories shares in Q2 2026, an estimated $34.9M.
  • Idexx Laboratories made up 0.06% of Allianz Asset Management's portfolio in Q2 2026, its #290 holding.
  • Allianz Asset Management first reported a position in Idexx Laboratories in Q4 2013 and has held it in 43 quarters since.
  • Allianz Asset Management's Idexx Laboratories position peaked at $199M in Q2 2021.
  • 1,305 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Allianz Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.